We are delighted to be the Forum Partner for ELRIG’s UK Forum “Outside the norm”, an event at the University of Warwick, Coventry, exploring engineering biology for drug discovery.
Partner Martin MacLean and Managing Associate Lionel Newton will be representing the firm at ELRIG’s UK Forum “Outside the norm”, taking place on the 13th of November.
Lionel Newton will be delivering a talk that explores how strategic intellectual property (IP) management underpins success in the advanced therapeutics sector. From early-stage spin-outs to clinical development and eventual acquisition, ventures that proactively build and evolve their patent portfolios are best positioned to attract investment, secure partnerships, and sustain competitive advantage. Drawing on real-world experience, including a brief case study, the session highlights how a well-planned IP strategy not only protects innovation but also drives commercial value throughout the therapeutic development.
About ELRIG
ELRIG is a not-for-profit organisation that brings together the global life science and drug discovery community through free-to-attend events. With a network of over 12,000 professionals, it is dedicated to promoting inclusion and accessibility whilst encouraging innovation across the sector. This event will highlight the use of synthetic biology and engineered biological systems in accelerating drug development, discovering new classes of medicines and unlocking previously undruggable targets.
Please reach out to our team if you are interested in arranging a meeting.
For more information on the event, visit the website here.
